Chief Scientific Officer
Coriolis Pharma
Martinsried, Bayern, Germany
Andrea Hawe, is co-founder and Chief Scientific Officer of Coriolis Pharma, a science-driven contract research organization supporting drug product development of biopharmaceuticals (protein, peptides, oligonucleotides ATMPs, vaccines, etc), with focus on formulation development, lyophilization technologies and analytics (GMP and non-GMP). Andrea has received her PhD degree in Pharmaceutical Technology from the Ludwig Maximilian University of Munich, Germany in the field of protein lyophilization and formulation. Prior to founding Coriolis Pharma in 2008, Andrea has worked as post doctoral scientist at Leiden University, The Netherlands, on different projects related to protein characterization, innovative fluorescence based methods, development of heat-stable formulations for third world countries and immunogenicity. She is an expert for protein formulation and protein characterization, and has published more than 50 articles in peer-reviewed journals.
Hot Topic: Novel Excipients in Biopharma: Balancing Innovation, Risk, and Need
Wednesday, October 25, 2023
3:00 PM – 4:00 PM ET